Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- Check3 days agoChange DetectedThe footer revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedResults Submitted appears and a new revision (v3.4.2) is listed; the 'No Results Posted' notice was removed.SummaryDifference0.3%

- Check81 days agoChange DetectedAdded a Notice about government funding lapse and NIH Clinical Center operating status. Updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check89 days agoChange DetectedThe update includes a glossary display option, a new 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' notice, and revision indicator (v3.4.0). Core study content, eligibility criteria, and results data remain unchanged.SummaryDifference0.1%

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.